MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien (MKKGY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for MERCK Kommanditgesellschaft auf Aktien (MKKGY), featuring income statements, balance sheets, and cash flow data.
MERCK Kommanditgesellschaft auf Aktien (MKKGY) Income Statement & Financial Overview
Analyze MERCK Kommanditgesellschaft auf Aktien’s MKKGY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.28B | $5.42B | $5.27B | $5.35B |
| Cost of Revenue | $2.13B | $2.32B | $2.12B | $2.12B |
| Gross Profit | $3.15B | $3.10B | $3.14B | $3.23B |
| Gross Profit Ratio | $0.60 | $0.57 | $0.60 | $0.60 |
| R&D Expenses | $551.00M | $527.00M | $524.00M | $647.00M |
| SG&A Expenses | $1.47B | $1.05B | $1.41B | $1.48B |
| Operating Expenses | $2.14B | $2.27B | $2.05B | $2.07B |
| Total Costs & Expenses | $4.27B | $4.59B | $4.17B | $4.56B |
| Interest Income | $28.00M | $24.00M | $35.00M | $65.00M |
| Interest Expense | $78.00M | $76.00M | $89.00M | $72.00M |
| Depreciation & Amortization | $473.00M | $551.00M | $449.00M | $680.00M |
| EBITDA | $1.51B | $1.42B | $1.58B | $1.54B |
| EBITDA Ratio | $0.29 | $0.26 | $0.30 | $0.29 |
| Operating Income | $1.006B | $824.00M | $1.10B | $792.00M |
| Operating Income Ratio | $0.19 | $0.15 | $0.21 | $0.15 |
| Other Income/Expenses (Net) | -$50.00M | -$15.00M | -$54.00M | -$7.00M |
| Income Before Tax | $956.00M | $809.00M | $1.04B | $785.00M |
| Income Before Tax Ratio | $0.18 | $0.15 | $0.20 | $0.15 |
| Income Tax Expense | $218.00M | $140.00M | $231.00M | $180.00M |
| Net Income | $735.00M | $667.00M | $809.00M | $607.00M |
| Net Income Ratio | $0.14 | $0.12 | $0.15 | $0.11 |
| EPS | $1.69 | $1.53 | $1.86 | $1.40 |
| Diluted EPS | $1.69 | $1.53 | $1.86 | $1.40 |
| Weighted Avg Shares Outstanding | $434.91M | $434.78M | $434.95M | $434.78M |
| Weighted Avg Shares Outstanding (Diluted) | $434.91M | $434.78M | $434.95M | $434.78M |
The company's financials show resilient growth, with revenue advancing from $5.35B in Q2 2024 to $5.28B in Q1 2025. Gross profit remained healthy with margins at 60% in Q1 2025 compared to 60% in Q2 2024. Operating income hit $1.006B last quarter, sustaining a consistent 19% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.51B. Net income rose to $735.00M, while earnings per share reached $1.69. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan